[S01GX11, alcaftadine, The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Hydroxyzine.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Hydroxyzine.]
[M03AB01, succinylcholine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Succinylcholine.]
[J01EC01, sulfamethoxazole, The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Hydroxyzine.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Hydroxyzine.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Hydroxyzine.]
[N03AX03, sulthiame, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sulthiame.]
[L02BA01, tamoxifen, The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Hydroxyzine.]
[N05CD07, temazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Temazepam.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Hydroxyzine.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Hydroxyzine.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Hydroxyzine.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Hydroxyzine.]
[S01HA03, tetracaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Hydroxyzine.]
[A04AD10, dronabinol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Hydroxyzine.]
[L04AX02, thalidomide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Hydroxyzine.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Hydroxyzine.]
[R06AD03, thiethylperazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiethylperazine.]
[N05CA19, thiopental, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N05AB08, thioproperazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Hydroxyzine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Hydroxyzine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Hydroxyzine.]
[N05AL03, tiapride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tiapride.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Hydroxyzine.]
[N02AX01, tilidine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tilidine.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Hydroxyzine.]
[M03BX04, tolperisone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.]
[N02AX02, tramadol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tramadol.]
[N06AF04, tranylcypromine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Hydroxyzine.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Hydroxyzine.]
[S01BA05, triamcinolone, The metabolism of Hydroxyzine can be increased when combined with Triamcinolone.]
[N05CD05, triazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.]
[A03AB12, mepenzolate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.]
[N05AD02, trifluperidol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trifluperidol.]
[N05AA05, triflupromazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Hydroxyzine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Hydroxyzine.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Hydroxyzine.]
[N03AC02, trimethadione, The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Hydroxyzine.]
[N06AA06, trimipramine, The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Hydroxyzine.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Hydroxyzine.]
[A03BB01, butylscopolamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Hydroxyzine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.]
[N06AX02, tryptophan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tryptophan.]
[M03AA02, tubocurarine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tubocurarine.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Hydroxyzine.]
[A10BH05, linagliptin, The metabolism of Hydroxyzine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Hydroxyzine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Hydroxyzine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Hydroxyzine.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Hydroxyzine.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Hydroxyzine.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Hydroxyzine.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Hydroxyzine.]
[C08DA01, verapamil, The metabolism of Hydroxyzine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Hydroxyzine.]
[S01AA13, fusidic acid, The metabolism of Hydroxyzine can be decreased when combined with Fusidic acid.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Hydroxyzine.]
[J05AE02, indinavir, The metabolism of Hydroxyzine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydroxyzine.]
[L01ED01, crizotinib, The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Hydroxyzine.]
[R03DC01, zafirlukast, The metabolism of Hydroxyzine can be decreased when combined with Zafirlukast.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Hydroxyzine.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Hydroxyzine.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Hydroxyzine.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Hydroxyzine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Hydroxyzine.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Hydroxyzine.]
[M03AC04, atracurium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Atracurium.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Atropine is combined with Hydroxyzine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Hydroxyzine.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Hydroxyzine.]
[H02AB11, prednylidene, The metabolism of Hydroxyzine can be increased when combined with Prednylidene.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Hydroxyzine.]
[M03BX01, baclofen, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Baclofen.]
[A08AA11, lorcaserin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lorcaserin.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Hydroxyzine.]
[V03AX03, cobicistat, The metabolism of Hydroxyzine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Hydroxyzine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Hydroxyzine can be decreased when it is combined with Enzalutamide.]
[N05CA04, barbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Barbital.]
[J05AE04, nelfinavir, The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Hydroxyzine.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.]
[N04BD02, rasagiline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.]
[C08CA13, lercanidipine, The metabolism of Hydroxyzine can be decreased when combined with Lercanidipine.]
[A03FA09, mosapride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mosapride.]
[N06DA02, donepezil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N03AX22, perampanel, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.]
[N02CC03, zolmitriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[R06AC06, thonzylamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diethyl ether.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Hydroxyzine.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Hydroxyzine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Hydroxyzine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Hydroxyzine.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Hydroxyzine.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Hydroxyzine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Hydroxyzine.]
[L04AX06, pomalidomide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.]
[N05AD07, benperidol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benperidol.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Hydroxyzine.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Hydroxyzine.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Hydroxyzine.]
[R02AD01, benzocaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Hydroxyzine.]
[N02CC02, naratriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naratriptan.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Hydroxyzine.]
[L01EC02, dabrafenib, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Hydroxyzine.]
[P03AX06, benzyl alcohol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.]
[N06AX28, levomilnacipran, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Bepridil is combined with Hydroxyzine.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Hydroxyzine.]
[N06AX26, vortioxetine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.]
[N03AF04, eslicarbazepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Hydroxyzine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Hydroxyzine.]
[C07AB04, acebutolol, The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Hydroxyzine.]
[N05CH03, tasimelteon, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Hydroxyzine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Hydroxyzine can be increased when combined with Apremilast.]
[N07CA01, betahistine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Hydroxyzine.]
[S03BA03, betamethasone, The metabolism of Hydroxyzine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Hydroxyzine.]
[L04AC11, siltuximab, The metabolism of Hydroxyzine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Hydroxyzine.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Hydroxyzine.]
[L01EM01, idelalisib, The metabolism of Hydroxyzine can be decreased when combined with Idelalisib.]
[N01AX05, alfaxalone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alfaxalone.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Hydroxyzine.]
[D11AA01, glycopyrronium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Hydroxyzine.]
[N05AA04, acepromazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.]
[N04AA02, biperiden, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Hydroxyzine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Hydroxyzine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Hydroxyzine.]
[N06AX11, mirtazapine, The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Hydroxyzine.]
[L04AC10, secukinumab, The metabolism of Hydroxyzine can be increased when combined with Secukinumab.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Hydroxyzine.]
[L01XH03, panobinostat, The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Hydroxyzine.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Hydroxyzine.]
[A03AA09, difemerine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Hydroxyzine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Hydroxyzine.]
[N05AX16, brexpiprazole, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.]
[G02CX02, flibanserin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.]
[N05AX15, cariprazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cariprazine.]
[S01EC01, acetazolamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.]
[N05AB07, acetophenazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Acetophenazine.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Hydroxyzine.]
[J02AC05, isavuconazole, The metabolism of Hydroxyzine can be decreased when combined with Isavuconazole.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Hydroxyzine.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Hydroxyzine.]
[N05CA05, aprobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Aprobarbital.]
[N03AX23, brivaracetam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Hydroxyzine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.]
[N04BC01, bromocriptine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromocriptine.]
[A03AX08, alverine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alverine.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Hydroxyzine.]
[N06AA19, amineptin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Amineptine.]
[C08CA01, amlodipine, The risk or severity of QTc prolongation can be increased when Amlodipine is combined with Hydroxyzine.]
[N06BX11, aniracetam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Aniracetam.]
[N01BB01, bupivacaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Hydroxyzine.]
[N07BC01, buprenorphine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Hydroxyzine.]
[N05BE01, buspirone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Buspirone.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Hydroxyzine.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Artemether is combined with Hydroxyzine.]
[N02AF01, butorphanol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Hydroxyzine.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Hydroxyzine.]
[S01GX07, azelastine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Hydroxyzine can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Hydroxyzine.]
[L01EF02, ribociclib, The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Hydroxyzine.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Deutetrabenazine is combined with Hydroxyzine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Hydroxyzine.]
[N03AX30, beclamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Beclamide.]
[S01HA02, benoxinate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.]
[J05AE09, tipranavir, The metabolism of Hydroxyzine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Hydroxyzine.]
[L04AB02, infliximab, The metabolism of Hydroxyzine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Hydroxyzine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Safinamide.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Hydroxyzine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Hydroxyzine.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Hydroxyzine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Hydroxyzine.]
[J05AG03, efavirenz, The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Hydroxyzine.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Hydroxyzine.]
[N04AA11, bornaprine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.]
[N05CD09, brotizolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.]
[R03BA02, budesonide, The metabolism of Hydroxyzine can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Hydroxyzine can be decreased when combined with Acalabrutinib.]
[N05CA03, butobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.]
[J05AX18, letermovir, The metabolism of Hydroxyzine can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Hydroxyzine.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Hydroxyzine.]
[N05CA08, butylvinal, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Hydroxyzine.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Hydroxyzine.]
[L02BB05, apalutamide, The metabolism of Hydroxyzine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[A03AA03, camylofine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Hydroxyzine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Hydroxyzine.]
[N03AX24, cannabidiol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Hydroxyzine.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Hydroxyzine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Hydroxyzine.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Hydroxyzine.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Hydroxyzine.]
[N03AX17, stiripentol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Hydroxyzine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Hydroxyzine.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Hydroxyzine.]
[N05CM04, carbromal, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carbromal.]
[N01BA04, chloroprocaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.]
[R06AA06, chlorphenoxamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Hydroxyzine.]
[M03BA02, carisoprodol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carisoprodol.]
[R03BB08, revefenacin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Hydroxyzine.]
[L04AA39, emapalumab, The metabolism of Hydroxyzine can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Hydroxyzine.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Hydroxyzine.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Hydroxyzine.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Hydroxyzine.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Hydroxyzine.]
[A03FA08, cinitapride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cinitapride.]
[S01ED05, carteolol, The risk or severity of QTc prolongation can be increased when Carteolol is combined with Hydroxyzine.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Hydroxyzine.]
[N06AX27, esketamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Esketamine.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Hydroxyzine.]
[N06BA14, solriamfetol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.]
[N06AX29, brexanolone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brexanolone.]
[N05BA09, clobazam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clobazam.]
[H02AB14, cloprednol, The metabolism of Hydroxyzine can be increased when combined with Cloprednol.]
[N05BA22, cloxazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cloxazolam.]
[L04AB01, etanercept, The metabolism of Hydroxyzine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Hydroxyzine can be increased when combined with Cortivazol.]
[N05AA06, cyamemazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Hydroxyzine.]
[M03BX08, cyclobenzaprine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyclobenzaprine.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Entrectinib is combined with Hydroxyzine.]
[N07XX11, pitolisant, The risk or severity of QTc prolongation can be increased when Pitolisant is combined with Hydroxyzine.]
[J01XX12, lefamulin, The risk or severity of QTc prolongation can be increased when Lefamulin is combined with Hydroxyzine.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Hydroxyzine.]
[G04BE04, yohimbine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Hydroxyzine.]
[N02CC08, lasmiditan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lasmiditan.]
[N03AX25, cenobamate, The serum concentration of Hydroxyzine can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Hydroxyzine.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Hydroxyzine.]
[N02AX03, dezocine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dezocine.]
[N05CM21, lemborexant, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.]
[N05AD10, lumateperone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.]
[J05AB16, remdesivir, The metabolism of Hydroxyzine can be decreased when combined with Remdesivir.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Hydroxyzine.]
[H02CA02, osilodrostat, The metabolism of Hydroxyzine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Hydroxyzine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Frovatriptan.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Hydroxyzine.]
[N05CC04, dichloralphenazone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Hydroxyzine.]
[A07DA04, difenoxin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.]
[N02AA08, dihydrocodeine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.]
[N02CC06, eletriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eletriptan.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Hydroxyzine.]
[C01BD07, dronedarone, The risk or severity of QTc prolongation can be increased when Dronedarone is combined with Hydroxyzine.]
[N03AG02, dipropylacetamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Valpromide.]
[S03AA08, chloramphenicol, The metabolism of Hydroxyzine can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Hydroxyzine.]
[N05BA02, chlordiazepoxide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Hydroxyzine can be decreased when combined with Tucatinib.]
[A03AA08, dihexyverine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[D07XB03, fluprednidene, The metabolism of Hydroxyzine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[L01EX22, selpercatinib, The risk or severity of QTc prolongation can be increased when Selpercatinib is combined with Hydroxyzine.]
[N05CM02, chlormethiazole, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.]
[M03BB02, chlormezanone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.]
[R02AD04, dyclonine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dyclonine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Hydroxyzine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Hydroxyzine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Fostemsavir.]
[N05CD14, remimazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Hydroxyzine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hydroxyzine is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Hydroxyzine.]
[L01EX23, pralsetinib, The metabolism of Hydroxyzine can be decreased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Hydroxyzine.]
[N05AA01, chlorpromazine, The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Hydroxyzine.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxyzine.]
[M03BB03, chlorzoxazone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.]
[N05BX03, etifoxine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.]
[N06BX18, vinpocetine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vinpocetine.]
[N05BA18, ethyl loflazepate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.]
[B06AC06, berotralstat, The metabolism of Hydroxyzine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Hydroxyzine can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Relugolix.]
[P03AX07, abametapir, The serum concentration of Hydroxyzine can be increased when it is combined with Abametapir.]
[M03BA05, febarbamate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Febarbamate.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Felbamate is combined with Hydroxyzine.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Hydroxyzine.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Hydroxyzine.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Formoterol is combined with Hydroxyzine.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Hydroxyzine.]
[N01AB05, trichloroethylene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.]
[A02BA01, cimetidine, The metabolism of Hydroxyzine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.]
[N07CA02, cinnarizine, The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Hydroxyzine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Hydroxyzine.]
[L01XX73, sotorasib, The serum concentration of Hydroxyzine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Hydroxyzine.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Citalopram is combined with Hydroxyzine.]
[P01CA03, fexinidazole, The metabolism of Hydroxyzine can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Mobocertinib is combined with Hydroxyzine.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Clemastine is combined with Hydroxyzine.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Hydroxyzine.]
[N06AX25, St. John's wort extract, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Hydroxyzine.]
[J04BA01, clofazimine, The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Hydroxyzine.]
[N01BB10, levobupivacaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Pacritinib is combined with Hydroxyzine.]
[N06AA04, clomipramine, The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Hydroxyzine.]
[N03AE01, clonazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Hydroxyzine.]
[C01EB24, mavacamten, The serum concentration of Hydroxyzine can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Hydroxyzine.]
[N05AH06, clothiapine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clothiapine.]
[N05BA21, clotiazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Hydroxyzine.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Granisetron is combined with Hydroxyzine.]
[L01XX77, adagrasib, The risk or severity of QTc prolongation can be increased when Adagrasib is combined with Hydroxyzine.]
[N05AH02, clozapine, The risk or severity of QTc prolongation can be increased when Clozapine is combined with Hydroxyzine.]
[N05BA13, halazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Halazepam.]
[H01AC08, somatrogon, The metabolism of Hydroxyzine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Hydroxyzine.]
[C02KB01, metyrosine, Hydroxyzine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Hydroxyzine can be increased when combined with Bimekizumab.]
[R05DA04, codeine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC05, hexafluorenium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.]
[A03AB10, hexocyclium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Hydroxyzine.]
[A04AA03, tropisetron, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tropisetron.]
[C04AX28, ifenprodil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Hydroxyzine.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Hydroxyzine.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Hydroxyzine.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Hydroxyzine.]
[N02CC05, almotriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.]
[J02AC02, itraconazole, The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Hydroxyzine.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Hydroxyzine.]
[N05BA10, ketazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Imatinib is combined with Hydroxyzine.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Hydroxyzine.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Hydroxyzine.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Hydroxyzine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Hydroxyzine.]
[S01BA03, cortisone, The metabolism of Hydroxyzine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Hydroxyzine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Hydroxyzine.]
[N05CD06, lormetazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.]
[A03AA04, mebeverine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Hydroxyzine.]
[H02AB15, meprednisone, The metabolism of Hydroxyzine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Hydroxyzine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Adenosine is combined with Hydroxyzine.]
[N04AA03, methixene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Hydroxyzine.]
[N05CA10, cyclobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyclobarbital.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Hydroxyzine.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Melperone is combined with Hydroxyzine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Hydroxyzine.]
[N06AX07, minaprine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Minaprine.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Hydroxyzine.]
[N06AG02, moclobemide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Moclobemide.]
[N06BA07, modafinil, The metabolism of Hydroxyzine can be increased when combined with Armodafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Hydroxyzine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Hydroxyzine.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Hydroxyzine.]
[C03XA02, conivaptan, The metabolism of Hydroxyzine can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Hydroxyzine.]
[G03XA01, danazol, The metabolism of Hydroxyzine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.]
[J04BA02, dapsone, The metabolism of Hydroxyzine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Hydroxyzine can be increased when combined with Daunorubicin.]
[N06BX04, deanol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Hydroxyzine.]
[G03XX01, prasterone, The metabolism of Hydroxyzine can be decreased when combined with Prasterone.]
[A04AD11, nabilone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nabilone.]
[N05BA16, nordazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Hydroxyzine.]
[N06AX06, nefazodone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.]
[N05CM16, niaprazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Niaprazine.]
[N03AG06, tiagabine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.]
[M03AC11, cisatracurium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cisatracurium.]
[R05DA06, normethadone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Normethadone.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Escitalopram is combined with Hydroxyzine.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Hydroxyzine.]
[N06AA01, desipramine, The risk or severity of QTc prolongation can be increased when Desipramine is combined with Hydroxyzine.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Hydroxyzine.]
[N03AF02, oxcarbazepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Hydroxyzine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxiracetam.]
[N04AA08, dexetimide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Hydroxyzine.]
[A03AA01, oxyphencyclimine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Hydroxyzine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Hydroxyzine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[R05DA09, dextromethorphan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dextromethorphan.]
[N03AC01, paramethadione, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Paramethadione.]
[N02AC01, dextromoramide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dextromoramide.]
[N06AB05, paroxetine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Hydroxyzine.]
[N07BC06, heroin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diamorphine.]
[N05BA01, diazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diazepam.]
[N03AX07, phenacemide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenacemide.]
[N03AD02, phensuximide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phensuximide.]
[N06AA08, dibenzepin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dibenzepin.]
[S02DA04, dibucaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Hydroxyzine.]
[A03AA07, dicyclomine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Hydroxyzine.]
[N05AD05, pipamperone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.]
[A03AB14, pipenzolate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The risk or severity of QTc prolongation can be increased when Erlotinib is combined with Hydroxyzine.]
[A08AA03, diethylpropion, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxyzine.]
[D07XC04, diflucortolone, The metabolism of Hydroxyzine can be increased when combined with Difluocortolone.]
[A03AB11, poldine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[C01AA04, digitoxin, The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Hydroxyzine.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxyzine.]
[N02CA01, dihydroergotamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dihydroergotamine.]
[N02AA03, hydromorphone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Hydroxyzine.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Hydroxyzine.]
[D04AB07, pramoxine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.]
[C08DB01, diltiazem, The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Hydroxyzine.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Hydroxyzine.]
[M03BX03, pridinol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pridinol.]
[R06AB03, dimethindene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[N03AG05, progabide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Progabide.]
[R06AA02, diphenhydramine, The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Hydroxyzine.]
[A07DA01, diphenoxylate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diphenoxylate.]
[N05CD10, quazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Quazepam.]
[N06BA11, dexmethylphenidate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dexmethylphenidate.]
[N06AA23, quinupramine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Cisapride is combined with Hydroxyzine.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Hydroxyzine.]
[N05AL04, remoxipride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Hydroxyzine.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Hydroxyzine.]
[S02AA12, rifamycin SV, The metabolism of Hydroxyzine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Hydroxyzine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Riluzole.]
[N05AX08, risperidone, The risk or severity of QTc prolongation can be increased when Risperidone is combined with Hydroxyzine.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Hydroxyzine.]
[N01BB09, ropivacaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Hydroxyzine.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Hydroxyzine.]
[A04AD12, aprepitant, The metabolism of Hydroxyzine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hydroxyzine.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Hydroxyzine.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Hydroxyzine.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Hydroxyzine.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Hydroxyzine.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Domperidone is combined with Hydroxyzine.]
[N06AA16, dothiepin, The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Hydroxyzine.]
[N06AA12, doxepin, The risk or severity of QTc prolongation can be increased when Doxepin is combined with Hydroxyzine.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Hydroxyzine.]
[N06AB06, sertraline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sertraline.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Hydroxyzine.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Hydroxyzine.]
[A08AA10, sibutramine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sibutramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Hydroxyzine.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Sultopride is combined with Hydroxyzine.]
[N02CC01, sumatriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sumatriptan.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Talinolol is combined with Hydroxyzine.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Temafloxacin is combined with Hydroxyzine.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Terodiline is combined with Hydroxyzine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Hydroxyzine.]
[M03BX07, tetrazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.]
[M03BX05, thiocolchicoside, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiocolchicoside.]
[N05AB05, thiopropazate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiopropazate.]
[G04BD01, emepronium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tianeptine.]
[N05BA23, tofisopam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tofisopam.]
[N06AG03, toloxatone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Toloxatone.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Hydroxyzine.]
[N03AX11, topiramate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Topiramate.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Toremifene is combined with Hydroxyzine.]
[N05CD11, triazulenone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Loprazolam.]
[N05CC01, chloral hydrate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.]
[N05CM07, triclofos, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triclofos.]
[A03AB08, tridihexethyl, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trimethobenzamide.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Hydroxyzine.]
[N04AA12, tropatepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Enflurane.]
[C02CA06, urapidil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Urapidil.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Hydroxyzine.]
[N05AL06, veralipride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Veralipride.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Hydroxyzine.]
[N06AX16, venlafaxine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Hydroxyzine can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Hydroxyzine.]
[N05CF01, zopiclone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N05AX11, zotepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zotepine.]
[C02AC02, guanfacine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Hydroxyzine.]
[G02AB03, ergonovine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.]
[C04AE01, ergoloid mesylates, USP, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ergoloid mesylate.]
[N02CA02, ergotamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ergotamine.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Hydroxyzine.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Hydroxyzine.]
[N05CD04, estazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Hydroxyzine.]
[R03BA05, fluticasone, The metabolism of Hydroxyzine can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Hydroxyzine.]
[C01CA15, gepefrine, Gepefrine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[N05CM08, ethchlorvynol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Hydroxyzine.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Hydroxyzine.]
[N04AA05, profenamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Hydroxyzine.]
[N03AB01, ethotoin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.]
[S01XA06, ethylmorphine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.]
[N01AX07, etomidate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Etomidate.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Hydroxyzine.]
[N05AE03, sertindole, The risk or severity of QTc prolongation can be increased when Sertindole is combined with Hydroxyzine.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Hydroxyzine.]
[L04AD02, tacrolimus, The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Hydroxyzine.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Hydroxyzine.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Astemizole is combined with Hydroxyzine.]
[R06AX12, terfenadine, The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Hydroxyzine.]
[N06AX12, bupropion, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bupropion.]
[N06AB08, fluvoxamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Hydroxyzine.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Hydroxyzine.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Hydroxyzine.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Felodipine is combined with Hydroxyzine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Fendiline is combined with Hydroxyzine.]
[N03AX26, fenfluramine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N02AB03, fentanyl, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fentanyl.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Hydroxyzine.]
[G04BD02, flavoxate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Flecainide is combined with Hydroxyzine.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Hydroxyzine.]
[N07CA03, flunarizine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.]
[N05CD03, flunitrazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Hydroxyzine can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Melitracen.]
[H02AB03, fluocortolone, The metabolism of Hydroxyzine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Hydroxyzine.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Hydroxyzine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Hydroxyzine.]
[N05AB02, fluphenazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N05CD01, flurazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flurazepam.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Hydroxyzine.]
[L02BB01, flutamide, The metabolism of Hydroxyzine can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Hydroxyzine.]
[M03AA01, alcuronium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alcuronium.]
[G01AX06, furazolidone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Furazolidone.]
[J05AE10, darunavir, The metabolism of Hydroxyzine can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Hydroxyzine.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Hydroxyzine.]
[M03AC02, gallamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gallamine.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Hydroxyzine.]
[N03AA04, barbexaclone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Barbexaclone.]
[N06AX08, bifemelane, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bifemelane.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Hydroxyzine.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Hydroxyzine.]
[L01EA02, dasatinib, The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Hydroxyzine.]
[N04BC06, cabergoline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cabergoline.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Hydroxyzine.]
[N01AH02, alfentanil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alfentanil.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Hydroxyzine.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Hydroxyzine.]
[N05CM18, dexmedetomidine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dexmedetomidine.]
[N05CE01, glutethimide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Hydroxyzine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Hydroxyzine.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Hydroxyzine.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Hydroxyzine.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Hydroxyzine.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Hydroxyzine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Hydroxyzine.]
[N01AB01, halothane, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Hydroxyzine.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Hydroxyzine.]
[N02CX03, iprazochrome, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Hydroxyzine.]
[N05CA21, allobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Allobarbital.]
[C09CA01, losartan, The risk or severity of QTc prolongation can be increased when Losartan is combined with Hydroxyzine.]
[N05CA16, hexobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Hydroxyzine.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Hydroxyzine.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Hydroxyzine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Hydroxyzine.]
[R05DA03, hydrocodone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Hydroxyzine.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Hydroxyzine.]
[G04BD06, propiverine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Hydroxyzine.]
[N05AX07, prothipendyl, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Hydroxyzine.]
[N07XX04, sodium oxybate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[R03BA09, fluticasone furoate, The metabolism of Hydroxyzine can be decreased when combined with Fluticasone furoate.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Hydroxyzine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Hydroxyzine.]
[N01AH03, sufentanil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sufentanil.]
[N06AA02, imipramine, The risk or severity of QTc prolongation can be increased when Imipramine is combined with Hydroxyzine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Hydroxyzine.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Hydroxyzine.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Hydroxyzine.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Hydroxyzine.]
[N06AX17, milnacipran, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.]
[A03AA30, piperidolate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Articaine.]
[N05BA12, alprazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.]
[N05CH02, ramelteon, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Hydroxyzine.]
[C10AA06, cerivastatin, The metabolism of Hydroxyzine can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Hydroxyzine.]
[C07AA01, alprenolol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alprenolol.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Hydroxyzine.]
[N06AA13, iprindole, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iprindole.]
[N06AF05, iproniazid, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iproniazid.]
[N05AA07, chlorproethazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorproethazine.]
[N06AF01, isocarboxazid, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Isocarboxazid.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Hydroxyzine.]
[N04BX02, entacapone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Entacapone.]
[J04AC01, isoniazid, The metabolism of Hydroxyzine can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Hydroxyzine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.]
[C02KD01, ketanserin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketanserin.]
[J02AB02, ketoconazole, The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Hydroxyzine.]
[N05AH03, olanzapine, The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Hydroxyzine.]
[L04AA24, abatacept, The metabolism of Hydroxyzine can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Hydroxyzine.]
[N04BC09, rotigotine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Hydroxyzine.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Hydroxyzine.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Hydroxyzine.]
[N03AX18, lacosamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lacosamide.]
[G03AD01, levonorgestrel, The metabolism of Hydroxyzine can be decreased when combined with Levonorgestrel.]
[N04BA01, levodopa, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levodopa.]
[S02DA01, lidocaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Hydroxyzine.]
[N06BA13, armodafinil, The metabolism of Hydroxyzine can be increased when combined with Armodafinil.]
[N02CA07, lisuride, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lisuride.]
[N06AA07, lofepramine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lofepramine.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Loperamide is combined with Hydroxyzine.]
[N05BA06, lorazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.]
[C10AA02, lovastatin, The metabolism of Hydroxyzine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Loxapine.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Hydroxyzine.]
[V04CC02, magnesium sulfate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.]
[P03AX03, malathion, The risk or severity of QTc prolongation can be increased when Malathion is combined with Hydroxyzine.]
[L01EA03, nilotinib, The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Hydroxyzine.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Hydroxyzine.]
[A08AA05, mazindol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mazindol.]
[R06AE05, meclizine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meclizine.]
[N05BA03, medazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Medazepam.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Hydroxyzine.]
[N05CH01, melatonin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Melatonin.]
[N02AB02, meperidine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meperidine.]
[C01CA11, mephentermine, Mephentermine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[N03AB04, mephenytoin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mephenytoin.]
[N03AA01, mephobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.]
[N01BB03, mepivacaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.]
[N05BC01, meprobamate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.]
[N02AX05, meptazinol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Hydroxyzine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Hydroxyzine.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Hydroxyzine.]
[N07BC02, methadone, The risk or severity of QTc prolongation can be increased when Methadone is combined with Hydroxyzine.]
[N06BA03, methamphetamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metamfetamine.]
[A03AB07, methantheline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.]
[N05CM01, methaqualone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.]
[N03AA30, metharbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metharbital.]
[G02CB05, metergoline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metergoline.]
[H03BB02, methimazole, The metabolism of Hydroxyzine can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.]
[N05CA15, methohexital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.]
[N02BG08, ziconotide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Hydroxyzine.]
[N02BG09, methoxyflurane, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.]
[V04CG05, methylene blue, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methylene blue.]
[N03AF03, rufinamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.]
[N05CE02, methyprylon, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methyprylon.]
[N02CA04, methysergide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methysergide.]
[A03FA01, metoclopramide, The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Hydroxyzine.]
[C07AB02, metoprolol, The metabolism of Metoprolol can be decreased when combined with Hydroxyzine.]
[P01AB01, metronidazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydroxyzine.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Hydroxyzine.]
[N06AX03, mianserin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mianserin.]
[S02AA13, miconazole, The metabolism of Hydroxyzine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Hydroxyzine.]
[N05CD08, midazolam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Hydroxyzine.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.]
[L01XX23, mitotane, The metabolism of Hydroxyzine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[N05AE02, molindone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Molindone.]
[C01BD01, amiodarone, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Hydroxyzine.]
[N06AA09, amitriptyline, The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Hydroxyzine.]
[N02AA01, morphine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Morphine.]
[A04AA05, palonosetron, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Hydroxyzine can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Hydroxyzine.]
[M03AC03, vecuronium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.]
[N05CA02, amobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Hydroxyzine.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Hydroxyzine.]
[N03AB05, fosphenytoin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Hydroxyzine.]
[N04BC04, ropinirole, Hydroxyzine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naftidrofuryl.]
[N02AF02, nalbuphine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.]
[V03AB15, naloxone, The metabolism of Hydroxyzine can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Hydroxyzine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of CNS depression can be increased when Naphazoline is combined with Hydroxyzine.]
[N06BA01, amphetamine, Amphetamine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[A10BG01, troglitazone, The metabolism of Hydroxyzine can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Duloxetine.]
[N04BX01, tolcapone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Hydroxyzine.]
[N01AH06, remifentanil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Hydroxyzine.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Hydroxyzine.]
[N06AX23, desvenlafaxine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.]
[N06AF02, nialamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nialamide.]
[C08CA04, nicardipine, The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Hydroxyzine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Hydroxyzine.]
[C08CA05, nifedipine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Hydroxyzine.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Hydroxyzine.]
[C08CA07, nisoldipine, The metabolism of Hydroxyzine can be decreased when combined with Nisoldipine.]
[N05CD02, nitrazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Hydroxyzine.]
[N05CF03, zaleplon, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.]
[N04BC05, pramipexole, Hydroxyzine may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.]
[N06AX04, nomifensine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nomifensine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Hydroxyzine.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Hydroxyzine.]
[N06AA10, nortriptyline, The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Hydroxyzine.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydroxyzine.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Hydroxyzine.]
[L04AC04, rilonacept, The metabolism of Hydroxyzine can be increased when combined with Rilonacept.]
[N06AA05, opipramol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Opipramol.]
[N02AA02, opium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Hydroxyzine.]
[N05BA04, oxazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Hydroxyzine.]
[C07AA02, oxprenolol, The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Hydroxyzine.]
[N02AA05, oxycodone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.]
[N02AA11, oxymorphone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.]
[N05AE01, oxypertine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxypertine.]
[A03AB03, oxyphenonium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydroxyzine.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Asenapine is combined with Hydroxyzine.]
[N02AX06, tapentadol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.]
[M03AC01, pancuronium, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Hydroxyzine.]
[N05CC05, paraldehyde, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The metabolism of Hydroxyzine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pargyline.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Hydroxyzine.]
[G04BD11, fesoterodine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Hydroxyzine.]
[N02AD01, pentazocine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pentazocine.]
[N05CA01, pentobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.]
[N05AB10, perazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perazine.]
[N04BC02, pergolide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pergolide.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Hydroxyzine.]
[N05AB03, perphenazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Hydroxyzine.]
[N02AD02, phenazocine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenazocine.]
[N06AF03, phenelzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenelzine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Hydroxyzine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Hydroxyzine.]
[N03AA02, phenobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.]
[N01AH04, phenoperidine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenoperidine.]
[A08AA01, phentermine, Phentermine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[N03AB02, phenytoin, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[L04AB06, golimumab, The metabolism of Hydroxyzine can be increased when combined with Golimumab.]
[S01AE08, besifloxacin, The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Hydroxyzine.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Hydroxyzine.]
[C08CX01, mibefradil, The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Hydroxyzine.]
[N05AG02, pimozide, The risk or severity of QTc prolongation can be increased when Pimozide is combined with Hydroxyzine.]
[C07AA03, pindolol, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Hydroxyzine.]
[J05AE01, saquinavir, The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Hydroxyzine.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Hydroxyzine.]
[N05AC04, pipothiazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.]
[A02BX03, pirenzepine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Piritramide.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Hydroxyzine.]
[N02CX01, pizotyline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Hydroxyzine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Proxibarbal.]
[A03AE01, alosetron, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alosetron.]
[L04AC08, canakinumab, The metabolism of Hydroxyzine can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Hydroxyzine.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Hydroxyzine.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Hydroxyzine.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Hydroxyzine.]
[N05BA11, prazepam, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Prazepam.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Hydroxyzine.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Antazoline is combined with Hydroxyzine.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Hydroxyzine.]
[N01BB04, prilocaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Primaquine is combined with Hydroxyzine.]
[N03AA03, primidone, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Primidone.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Probucol is combined with Hydroxyzine.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Procainamide is combined with Hydroxyzine.]
[S01HA05, procaine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[L01XB01, procarbazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Hydroxyzine.]
[N04AA04, procyclidine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Hydroxyzine can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of QTc prolongation can be increased when Promazine is combined with Hydroxyzine.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Promethazine is combined with Hydroxyzine.]
[C01BC03, propafenone, The risk or severity of QTc prolongation can be increased when Propafenone is combined with Hydroxyzine.]
[N01AX04, propanidid, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Propanidid.]
[A03AB05, propantheline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Periciazine.]
[N05CM06, propiomazine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Hydroxyzine.]
[N01AX10, propofol, The risk or severity of QTc prolongation can be increased when Propofol is combined with Hydroxyzine.]
[N02AC04, propoxyphene, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dextropropoxyphene.]
[C07AA05, propranolol, The risk or severity of QTc prolongation can be increased when Propranolol is combined with Hydroxyzine.]
[N02CC04, rizatriptan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Hydroxyzine.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the sedative and stimulatory activities of Hydroxyzine.]
[N05AX12, aripiprazole, The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Hydroxyzine.]
[S01EB03, ecothiopate, The risk or severity of QTc prolongation can be increased when Echothiophate is combined with Hydroxyzine.]
[A03AB15, diphemanil, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Talbutal.]
[N05CA09, vinbarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vinbarbital.]
[N05BB02, captodiamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Captodiame.]
[M03BA04, styramate, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Styramate.]
[P02CC01, pyrantel, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Hydroxyzine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Hydroxyzine.]
[C01BA01, quinidine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Hydroxyzine.]
[P01BC01, quinine, The risk or severity of QTc prolongation can be increased when Quinine is combined with Hydroxyzine.]
[C02AA02, reserpine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Reserpine.]
[J04AB02, rifampin, The metabolism of Hydroxyzine can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Hydroxyzine.]
[S01FA02, scopolamine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.]
[N04BD01, selegiline, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Selegiline.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Sotalol is combined with Hydroxyzine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Hydroxyzine.]
[H02CA04, levoketoconazole, The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Hydroxyzine.]
[R03BB01, ipratropium bromide, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
